TY - JOUR
T1 - The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
AU - Page, Matthew J
AU - McKenzie, Joanne E
AU - Bossuyt, Patrick M
AU - Boutron, Isabelle
AU - Hoffmann, Tammy C
AU - Mulrow, Cynthia D
AU - Shamseer, Larissa
AU - Tetzlaff, Jennifer M
AU - Akl, Elie A
AU - Brennan, Sue E
AU - Chou, Roger
AU - Glanville, Julie
AU - Grimshaw, Jeremy M
AU - Hróbjartsson, Asbjørn
AU - Lalu, Manoj M
AU - Li, Tianjing
AU - Loder, Elizabeth W
AU - Mayo-Wilson, Evan
AU - McDonald, Steve
AU - McGuinness, Luke A
AU - Stewart, Lesley A
AU - Thomas, James
AU - Tricco, Andrea C
AU - Welch, Vivian A
AU - Whiting, Penny
AU - Moher, David
PY - 2021/3/29
Y1 - 2021/3/29
N2 - The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement, published in 2009, was designed to help systematic reviewers transparently report why the review was done, what the authors did, and what they found. Over the past decade, advances in systematic review methodology and terminology have necessitated an update to the guideline. The PRISMA 2020 statement replaces the 2009 statement and includes new reporting guidance that reflects advances in methods to identify, select, appraise, and synthesise studies. The structure and presentation of the items have been modified to facilitate implementation. In this article, we present the PRISMA 2020 27-item checklist, an expanded checklist that details reporting recommendations for each item, the PRISMA 2020 abstract checklist, and the revised flow diagrams for original and updated reviews.Summary pointsTo ensure a systematic review is valuable to users, authors should prepare a transparent, complete, and accurate account of why the review was done, what they did, and what they foundThe PRISMA 2020 statement provides updated reporting guidance for systematic reviews that reflects advances in methods to identify, select, appraise, and synthesise studiesThe PRISMA 2020 statement consists of a 27-item checklist, an expanded checklist that details reporting recommendations for each item, the PRISMA 2020 abstract checklist, and revised flow diagrams for original and updated reviewsWe anticipate that the PRISMA 2020 statement will benefit authors, editors, and peer reviewers of systematic reviews, and different users of reviews, including guideline developers, policy makers, healthcare providers, patients, and other stakeholders
AB - The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement, published in 2009, was designed to help systematic reviewers transparently report why the review was done, what the authors did, and what they found. Over the past decade, advances in systematic review methodology and terminology have necessitated an update to the guideline. The PRISMA 2020 statement replaces the 2009 statement and includes new reporting guidance that reflects advances in methods to identify, select, appraise, and synthesise studies. The structure and presentation of the items have been modified to facilitate implementation. In this article, we present the PRISMA 2020 27-item checklist, an expanded checklist that details reporting recommendations for each item, the PRISMA 2020 abstract checklist, and the revised flow diagrams for original and updated reviews.Summary pointsTo ensure a systematic review is valuable to users, authors should prepare a transparent, complete, and accurate account of why the review was done, what they did, and what they foundThe PRISMA 2020 statement provides updated reporting guidance for systematic reviews that reflects advances in methods to identify, select, appraise, and synthesise studiesThe PRISMA 2020 statement consists of a 27-item checklist, an expanded checklist that details reporting recommendations for each item, the PRISMA 2020 abstract checklist, and revised flow diagrams for original and updated reviewsWe anticipate that the PRISMA 2020 statement will benefit authors, editors, and peer reviewers of systematic reviews, and different users of reviews, including guideline developers, policy makers, healthcare providers, patients, and other stakeholders
UR - http://www.scopus.com/inward/record.url?scp=85103745198&partnerID=8YFLogxK
U2 - 10.1371/journal.pmed.1003583
DO - 10.1371/journal.pmed.1003583
M3 - Article
C2 - 33780438
SN - 1549-1277
VL - 18
JO - PLoS Medicine
JF - PLoS Medicine
IS - 3
M1 - e1003583
ER -